Non-alcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Non-alcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 trial of Tropifexor (LJN452) in non-alcoholic steatohepatitis was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-14Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH [Phase 2]
Phase 2 trial evaluating two doses of Aramchol versus placebo in non-alcoholic steatohepatitis (NASH) completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis. [Phase 2]
Phase 2 trial evaluating three dose levels of subcutaneous semaglutide once daily vs placebo in non-alcoholic steatohepatitis; study complet…
-
CLINICAL_TRIALS trial_result · 2021-04-12Clinical Trial Update: Phase 2b Study in NASH to Assess IVA337 [Phase 2]
Phase 2b study in NASH (IVA337) has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 clinical trial of Siliphos in adults with fatty liver (NASH) completed; results posted in 2021.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH) [Phase 3]
Investigator-initiated Phase 3 randomized trial comparing saroglitazar, vitamin E, and lifestyle modification for NAFLD/NASH.
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients [Phase 2]
Phase 2 trial assessing LIK066 for reducing fatty content in livers of obese patients with non-alcoholic steatohepatitis (NASH); study compl…
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial evaluating the effect of Nesinaact on non-alcoholic steatohepatitis in patients with type 2 diabetes using MRI and …
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Efficacy and Safety of Montelukast in Non Alcoholic Steatohepatitis (NASH) [Phase 4]
Phase 4 trial evaluating efficacy and safety of montelukast in non-alcoholic steatohepatitis has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH [Phase 2]
Phase 2 study assessing safety, tolerability, and efficacy of MSDC-0602K in patients with non-alcoholic fatty liver disease and non-alcoholi…
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease [Phase 2]
Phase 2 study evaluating CF102 for non-alcoholic steatohepatitis (NASH) has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: 2-Week Study In People With Nonalcoholic Fatty Liver Disease [Phase 1]
A Phase 1 clinical trial update for a two-week study in adults with nonalcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatit…
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis [Phase 2]
A Phase 2 clinical trial of IMM-124E for non-alcoholic steatohepatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-19Clinical Trial Update: A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 sub-study update for the BMS-986036 program in non-alcoholic steatohepatitis (NASH) with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-28Clinical Trial Update: A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 trial of BMS-986036 in non-alcoholic steatohepatitis (NASH) has completed, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH [Phase 2]
Phase 2 trial update for LMB763 in non-alcoholic steatohepatitis (NASH) has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 trial of Volixibat (SHP626) in adults with nonalcoholic steatohepatitis was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH) [Phase 2]
Phase 2 clinical trial update on MT-3995 for non-alcoholic steatohepatitis (NASH) reporting efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis [Phase 2]
A Phase 2 clinical trial evaluating emricasan, a caspase inhibitor, for non-alcoholic steatohepatitis with fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3 [Phase 2]
Phase 2 trial assessing GS-4997 alone or with simtuzumab in adults with NASH and fibrosis (F2-F3); study completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2019-04-18Clinical Trial Update: EUS Guided Core Liver Biopsy and IGB Placement for the Diagnosis and Management of NASH and Obesity [NA]
A completed clinical trial investigating EUS-guided core liver biopsy and intragastric balloon placement for diagnosing and managing obesity…
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis [Phase 2]
Phase 2 clinical trial update for emricasan, a caspase inhibitor, in subjects with decompensated cirrhosis due to non-alcoholic steatohepati…
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: BREATHID Octanoate Breath Test With or Without Methacetin Breath Test for Correlation With Biopsy in NASH [Phase 2]
Phase 2 clinical trial evaluating BREATHID Octanoate Breath Test with or without Methacetin Breath Test for correlation with biopsy in non-a…
-
CLINICAL_TRIALS research · 2018-05-11Clinical Trial Update: Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis [Phase 2]
A Phase 2 clinical trial update for atorvastatin and L-Carnitine in non-alcoholic steatohepatitis; the trial status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis [Phase 1]
This update notes a completed Phase 1 trial evaluating the metabolic effects of SGLT2 inhibitors in combination with metformin for non-alcoh…